Clinical Study of Multi-mode Thermal Ablation for the Treatment of Pancreatic Cancer With Liver Metastasis - Trial NCT06307080
Access comprehensive clinical trial information for NCT06307080 through Pure Global AI's free database. This phase not specified trial is sponsored by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine and is currently Recruiting. The study focuses on Pancreatic Cancer. Target enrollment is 12 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Timeline & Enrollment
N/A
Oct 08, 2023
Dec 31, 2024
Primary Outcome
Safety and efficacy assessment
Summary
1. Clinical evaluation of multimodal ablation system for pancreatic cancer with hepatic
 metastatic malignancies.
 
 2. Construction of a combined treatment system of multimodal ablation therapy combined with
 immunotherapy and chemotherapy.
 
 3. Transformation and clinical application of multimodal ablation system for pancreatic
 cancer with hepatic metastatic malignancies.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06307080
Device Trial